Pediatric Poisoning

Introduction

Gastric decontamination

Whole Bowel Irrigation

Initial management

Syrup of Ipecac

Treatment algorithm

Depressed mental status

Orogastric tube lavage

Specific Toxins and Antidotes

Labs

Activated Charcoal

Introduction

Patients less than 17 years of age account for 66 percent of reported exposures and 9 percent of all fatalities from poisoning. Medications, including iron, alcohol, hydrocarbons, and carbon monoxide are some of the most common and serious agents; the kitchen and the bathroom are the locations where most ingestion in children occur.

Initial management

Patients present an average of 68 minutes after the ingestion.

  • First and foremost is the evaluation and management of the ABCs (airway, breathing, and circulation).

  • History: Agent, time, and amount ingested, any symptoms, medical history, if unknown: consider occupation, search of location.

  • Physical Exam: Vital signs, mental status, pupillary signs, skin, odor.

If the patient has a depressed mental status

  • Dextrose 0.5-1.0 g/kg, 2-4 cc/kg D 25 for a child or 50cc D 50 for a teenager; may repeat boluses or infusion, or give glucagon 1 mg IM if no IV access.

  • Naloxone 2mg (1mg/cc), can repeat Q2-5min to total 10mg; lasts 20-30 min; may need repeat boluses.

  • The differential diagnosis for depressed mental status includes sepsis, meningitis, trauma, seizures, hypo/hyperthermia, central nervous system (CNS) mass lesions, and metabolic derangement.

Labs

Dextrostix, serum glucose, electrolytes, monitor/EKG, toxicology of blood/serum/vomitus, arterial blood gas (ABG), abdominal films. Especially look for arrhythmias, metabolic acidosis, seizures, and GI disturbance.

Gastric decontamination

Traditional methods of lavage, catharsis, and activated charcoal are undergoing reassessment; each has benefits and risks that apply to individual cases. Before choosing an intervention, the physician must determine:

  • Is gastric emptying indicated? The substance may be either nontoxic or potentially lethal, or there may be a contraindication to emptying (acid/alkali).

  • Is the substance still present in the stomach and is decontamination likely to work? The substance may be rapidly absorbed, may decrease GI motility, or the patient may already have vomited.

Decontamination

Clinical studies to compare efficacy of techniques are limited. Syrup of Ipecac and lavage are considered to have generally equal efficacy in clearing the stomach; activated charcoal is the most frequently used and the most effective decontamination agent. Certain patients can be treated appropriately without gastric emptying and with activated charcoal only.

Syrup of Ipecac

This should not be used routinely. Dose: 6-12months, 10 cc; 1-10years of age, 30cc; follow with water; induces emesis within 20-60 minutes.

Disadvantages:

  • Patient must be conscious, have a good gag, and no potential for decrease in mental status (this rules out many serious ingestions).

  • Must use within 1 hour of ingestion.

  • Protracted emesis delays giving activated charcoal.

  • Avoid with caustics or hydrocarbons.

Advantages:

  • May occasionally be helpful immediately after ingestion at home.

  • May be helpful in a small child who can't tolerate a large bore tube.

Lavage 36-40 F orogastric tube.

Can use in any patient with a potentially toxic ingestion, in whom toxin may still be present, where procedure can be done safely. If the mental status is depressed, you must intubate first to prevent aspiration.

Activated Charcoal

  • When: Recommended after ingestion of an agent that may be absorbed (not iron, lithium, and heavy metals).

  • Avoid if GI obstruction is present or suspected, or if endoscopy may be necessary (acid and alkali ingestions).

  • Complications include vomiting, diarrhea, and aspiration. Remember to intubate first if the mental status is depressed.

  • Dose: 1-2 g/kg, made as a slurry with H2O or sorbitol to 25%; aim for charcoal: poison ratio of 10:1.

Multiple dose regimen: Can increase adsorptive capacity, prevent reabsorption of poison in enterohepatic circulation, and enhance elimination with gut dialysis (creates concentration gradient):

  • Repeat 1 g/kg every 2-4 hours; may use smaller doses more frequently and antiemetics if necessary.

  • Avoid sorbitol in repeat doses (electrolyte instability).

  • Very useful especially for theophylline, aspirin, Tegretol, phenobarbitol, and tricyclics.

Acetaminophen overdose. Although charcoal may bind N-acetylcysteine (NAC), there is no evidence that activated charcoal inhibits efficacy. Activated charcoal can be alternated Q2 hr with NAC, each at its own 4-hr interval. Treatment with NAC has priority over treatment with activated charcoal in a patient with a toxic acetaminophen level.

Whole Bowel Irrigation

Used safely in surgical preps, e.g., Golytely, Colyte; 0.5L/hr for a small child, 2 L/hr for a teen, until clear (4-6 L per hr). This treatment can be considered for patients who ingest a substance that is absorbed by charcoal; massive ingestion; or patients who don't tolerate charcoal.

Pediatric poisoning treatment algorithm

PedPoison.gif (52781 bytes)

Specific Toxins and Antidotes

Acetaminophen

N-acetylcysteine (Mucomyst)

Load: 140 mg/kg (PO)

Maintenance: 70 mg/kg x 17 doses every 4 hours.

Anticholinergic

Physostigmine

Child: 0.01-0.03 mg/kg up to 0.5 mg slowly IV (over 5 to 10 minutes)

Use only with extreme caution.

Anticholinesterases

Atropine

0.05 mg/kg IM/IV every 5 to 10 minutes until secretions dried or full

atropinization occurs.

Organophosphates

Pralidoxime chloride (2-PAM)

Children: 25-50 mg/kg IV slowly; may repeat dose in one hour

Alcohols, Methanol,

Ethylene glycol

Ethanol

Load: 10ml/kg of 10% ethanol in D5W

Maintenance: 1.5 ml/kg/hour of same. Achieve ethanol level of 100 mg/dl

Benzodiazapines

Flumazenil

0.01 mg/kg IV

Beta blockers

Glucagon

50-150 mcg/kg IV

Carbon Monoxide

Oxygen

100% by tight-fitting mask or hyperbaric oxygen.

Cyanide

Sodium nitrite

0.33 ml (10ml)/kg IV of 3% solution

Sodium thiosulfate

1.65 ml/kg IV of 25% solution (must reduce if Hgb less than 12 gm to prevent

MetHgb

Digoxin

Fab antibodies (Digibind)

Dose is based upon estimated body burden. See package insert.

Iron

Deferoxamine

Begin at 5 - 15 mg/kg/hour. Monitor for hypotension during infusion.

Consider whole bowel irrigation.

Isoniazid (INH)

Pyridoxine 5 to 10%

1 gram per gram of INH ingested, IV slowly over 30 to 60 minutes.

Narcotics

Naloxone

0.1 mg/kg IV/IM/ETT/IO Newborn to 5 years (20kg), then 2 mg minimum.

Warfarin

Vitamin K

1 - 5 mg IV/IM/SC/PO

 

Remember

  • Contact a local/national poison control center; document their advice for treatment of the patient.

  • Know the substances tested by the lab's drug and toxicologic screens, and the time it takes to run them.

Reviewed by CDR Wendy Bailey, MC, USN, Pediatric Specialty Leader, Naval Medical Center San Diego, San Diego, CA (1999).

Preface  ·  Administrative Section  ·  Clinical Section

The General Medical Officer Manual , NAVMEDPUB 5134, January 1, 2000
Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This web version of The General Medical Officer Manual, NAVMEDPUB 5134 is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy version, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense. All material in this version is unclassified. This formatting © 2006 Medical Education Division, Brookside Associates, Ltd. All rights reserved.

Home  ·  Textbooks and Manuals  ·  Videos  ·  Lectures  ·  Distance Learning  ·  Training  ·  Operational Safety  ·  Search


This website is dedicated to the development and dissemination of medical information that may be useful to those who practice Operational Medicine. This website is privately-held and not connected to any governmental agency. The views expressed here are those of the authors, and unless otherwise noted, do not necessarily reflect the views of the Brookside Associates, Ltd., any governmental or private organizations. All writings, discussions, and publications on this website are unclassified.

© 2006 Medical Education Division, Brookside Associates, Ltd. All rights reserved

Other Brookside Products

Contact Us

 

Advertise on this Site